logo

For the Inventor, By the Inventor

Santa Barbara, CA, United States of America

Byron C Robinson

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.0

ph-index = 9

Forward Citations = 302(Granted Patents)


Company Filing History:

goldMedal10 out of 10 
 
Miravant Pharmaceuticals, Inc.
 patents
silverMedal3 out of 3 
 
Pdt Pharmaceuticals, Inc.
 patents

Years Active: 1998-2009

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7521551 - Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy (2009-04-21),
2. 6906050 - Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis (2005-06-14),
3. 6827926 - Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy (2004-12-07),
4. 6794505 - Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy (2004-09-21),
5. 6605606 - Solid forms of tin ethyl etiopurpurin and processes for producing such forms (2003-08-12),
6. 6462192 - Processes for large scale production of tetrapyrroles (2002-10-08),
7. 6444194 - Indium photosensitizers for PDT (2002-09-03),
8. 6376483 - Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production (2002-04-23),
9. 6054449 - Compounds and method for PDT of intimal hyperplasia and other diseases (2000-04-25),
10. 6008211 - Photoactivatable compounds comprising benzochlorin and furocoumarin (1999-12-28),
11. 5973141 - Method for the demethoxycarbonylation of porphyrinic compounds such as (1999-10-26),
12. 5789586 - Efficient functionalization of porphyrin derivatives possessing sulfonic (1998-08-04),
13. 5773609 - Photoactivatable compositions and to methods for the diagnosis and (1998-06-30),

Title: Byron C. Robinson: Innovator in Photodynamic Therapy

Introduction

Byron C. Robinson is a notable inventor based in Santa Barbara, CA (US). He has made significant contributions to the field of photodynamic therapy through his innovative research and development of chlorins and porphyrins. With a total of 13 patents, Robinson's work has paved the way for advancements in medical treatments.

Latest Patents

Robinson's latest patents include groundbreaking inventions such as "Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy." This invention outlines a process for preparing naphthochlorins and other chlorins with annelated ring systems, which are essential for effective photodynamic therapy. The method involves using specific precursors and acid catalysts to achieve the desired chemical transformations. Another significant patent is focused on "Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging, and MRI diagnosis." This patent highlights the pharmaceutical applications of these compounds in various diagnostic and therapeutic contexts.

Career Highlights

Throughout his career, Robinson has worked with prominent companies in the pharmaceutical industry, including Miravant Pharmaceuticals, Inc. and PDT Pharmaceuticals, Inc. His expertise in photodynamic therapy has been instrumental in developing new treatment options for patients.

Collaborations

Robinson has collaborated with esteemed colleagues such as Avinash S. Phadke and Alan R. Morgan. These partnerships have further enhanced his research and contributed to the advancement of innovative therapies.

Conclusion

Byron C. Robinson's contributions to the field of photodynamic therapy through his patents and collaborations demonstrate his commitment to innovation in medical science. His work continues to influence the development of effective treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…